As research progresses, the focus will likely expand beyond structural imaging to include longitudinal studies of cognition, emotional regulation, and neurological disease risk... Mar 02
... Oct 31
ObsEva, today announced topline 52-week PRIMROSE 1 and 76-week PRIMROSE 2 results of Yselty, in development for the treatment of women with heavy ... Dec 10
Women are affected both as partners of male substance users and as substance users themselves. Let's have an understanding of know better... Jun 25
-Advertisements-